SLGL
Sol Gel Technologies Ltd
NASDAQ: SLGL · HEALTHCARE · BIOTECHNOLOGY
$74.04
+3.70% today
Updated 2026-04-30
Market cap
$230.14M
P/E ratio
—
P/S ratio
11.87x
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$4 – $98
Volume
0.0M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
10.0
Growth
A+5.0
Quality
C+2.0
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$110.00
+48.57%
12-Month target
—
—
Intrinsic (DCF)
$144.58
Margin of safety
+54.28%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 150.40% QoQ
+ 54.28% below intrinsic value
Risks
- Thin margins at -31.60%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.88M | $1.55M | $11.54M | $19.39M | $19.39M |
| Net income | $-14.92M | $-27.24M | $-10.58M | $-6.13M | $-2.99M |
| EPS | — | — | — | — | $-2.19 |
| Free cash flow | $-9.65M | $-17.86M | $-13.89M | $275000.00 | — |
| Profit margin | -384.32% | -1,752.77% | -91.70% | -31.60% | -31.60% |
Peer comparison
Smart narrative
Sol Gel Technologies Ltd trades at $74.04. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $19.39M. with profit margins at -31.60%. Our DCF model estimates intrinsic value at $144.58.
Frequently asked questions
What is Sol Gel Technologies Ltd's stock price?
Sol Gel Technologies Ltd (SLGL) trades at $74.04.
Is Sol Gel Technologies Ltd overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell). DCF value $144.58.
What is the price target of Sol Gel Technologies Ltd (SLGL)?
The analyst target price is $110.00, representing +48.6% upside from the current price of $74.04.
What is the intrinsic value of Sol Gel Technologies Ltd (SLGL)?
Based on our DCF model, intrinsic value is $144.58, a +54.3% margin of safety versus $74.04.
What is Sol Gel Technologies Ltd's revenue?
TTM revenue is $19.39M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio11.87x
ROE-23.70%
Beta1.27
50D MA$79.42
200D MA$46.54
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—